SCYNEXIS Director Acquires $500,000 in Stock (SCYX)
SCYNEXIS (NASDAQ:SCYX) Director Jean-Yves Nothias acquired 50,000 shares of the stock on the open market in a transaction that occurred on Wednesday, May 7th. The stock was purchased at an average price of $10.00 per share, with a total value of $500,000.00. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.
SCYNEXIS (NASDAQ:SCYX) traded down 0.92% on Thursday, hitting $8.59. The stock had a trading volume of 71,935 shares. SCYNEXIS has a 1-year low of $8.07 and a 1-year high of $9.84. The stock’s 50-day moving average is $8.6 and its 200-day moving average is $8.6. The company’s market cap is $72.6 million.
SCYNEXIS, Inc is a pharmaceutical company committed to the discovery, development and commercialization of anti-infectives to address unmet therapeutic needs.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.